Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Cardinal Health

A federal judge sides with 3 major drug distributors in a landmark opioid lawsuit

The lawsuit accused them of causing a health crisis by distributing 81 million pills over eight years in one West Virginia county ravaged by opioid addiction.

WEKU

Benzinga's Top Ratings Upgrades, Downgrades For May 26, 2022

Upgrades

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 18, 2022

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Idaho announces $119 million opioid crisis settlement

Idaho Gov. Brad Little and Attorney General Lawrence Wasden say it's the second-largest consumer settlement in state history.

WEKU

Idaho announces $119 million opioid crisis settlement

Idaho officials have announced a $119 million settlement with drugmaker Johnson & Johnson and three major distributors over their role in the opioid addiction crisis

The Independent UK

Cardinal Health's Shares Fall as Inflation and Supply Chain Constraints Hit Q3 Earnings

Cardinal Health Inc (NYSE:CAH) has reported Q3 FY22 adjusted EPS of $1.45, down 5% Y/Y, missing the consensus of $1.52 Q2 sales increased 14% Y/Y to $44.8 billion, beating the consensus estimate of $43.16 billion. The pharmaceutical segment increased 17% to $41 billion, driven primarily by branded pharmaceutical sales growth from large…

Benzinga

Cardinal Health: Q3 Earnings Insights

Cardinal Health (NYSE:CAH) reported its Q3 earnings results on Thursday, May 5, 2022 at 06:45 AM. Here's what investors need to know about the announcement.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Washington, Drug Distributors Reach $518M Settlement For Opioid Claims

Washington has reached a $518 million settlement with drug distributors McKesson Corporation (NYSE:MCK), AmerisourceBergen Corp (NYSE:ABC), and Cardinal Health Inc (NYSE:CAH) to resolve opioid-related claims. Washington opted out of a $26 billion nationwide opioid settlement involving the three drug distributors and Johnson & Johnson (NYSE:JNJ). Reuters writes that it would…

Benzinga

J&J's Janssen settles with WVa for $99M in opioid lawsuit

West Virginia will receive $99 million in a settlement finalized with Johnson & Johnson’s subsidiary Janssen Pharmaceuticals Inc. The state filed a lawsuit accusing the drugmaker of contributing to the opioid crisis in the state that's led the nation in overdose deaths

The Independent UK

WVa trial expert: Drug makers downplayed risks in marketing

Lawyers for the state of West Virginia are concluding the first week of a trial against three major opioid makers

The Independent UK

US drug czar testifies in WVa lawsuit against opioid makers

The new White House drug czar has testified that the opioid epidemic got so bad in drug-ravaged West Virginia that the state was having trouble finding foster parents to care for children

The Independent UK

Trial begins in West Virginia lawsuit against opioid makers

Opening arguments have taken place in a West Virginia lawsuit accusing several drugmakers of misrepresenting the risks and benefits of opioids

The Independent UK

This Favorable Sign Appears On Cardinal Health's Chart

If history is any guide, there may be good fortune ahead for shares of Cardinal Health (NYSE:CAH). A so-called "golden cross" has formed on its chart and, not surprisingly, this could be bullish for the stock.

Benzinga

Drug Distributors, JNJ Agree To Settle $26B Opioid Lawsuits

Distributors McKesson Corporation (NYSE: MCK), AmerisourceBergen Corp (NYSE: ABC), Cardinal Health Inc (NYSE: CAH

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Expert Ratings For Cardinal Health

Analysts have provided the following ratings for Cardinal Health (NYSE:CAH) within the last quarter:

Benzinga

Where Cardinal Health Stands With Analysts

Analysts have provided the following ratings for Cardinal Health (NYSE:CAH) within the last quarter:

Benzinga

Cardinal Health's Return on Invested Capital Insights

According to Benzinga Pro data Cardinal Health (NYSE:CAH) posted a 81.99% decrease in earnings from Q1. Sales, however, increased by 3.39% over the previous quarter to $45.46 billion.

Benzinga

Cardinal Health's Q4 Earnings Hit By Inflationary Impacts, Supply Chain Constraints; Lowers FY22 Outlook

Cardinal Health (NYSE: CAH) has reported Q2 FY22 adjuste

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Recap: Cardinal Health Q2 Earnings

Cardinal Health (NYSE:CAH) reported its Q2 earnings results on Thursday, February 3, 2022 at 06:45 AM. Here's what investors need to know about the announcement.

Benzinga

Cardinal Health's Earnings Outlook

Cardinal Health (NYSE:CAH) is set to give its latest quarterly earnings report on Thursday, 2022-02-03. Here's what investors need to know before the announcement. Analysts estimate that Cardinal Health will likely report an Earnings Per Share (EPS) of $1.23.

The Independent UK

Drug distributor to pay $13M to settle kickback allegations

Federal authorities say pharmaceutical distributor Cardinal Health Inc. has agreed to pay more than $13 million to resolve allegations that it violated federal law by paying kickbacks to some doctors’ offices

1 2 3

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.